Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Healthcare, Pharmaceuticals & Biotechnology Pharmaceuticals Pharmaceuticals: Global Industry Guide
Publications

(Currently 512486 Items)


Partners


Pharmaceuticals / REPORT INFORMATION

Pharmaceuticals: Global Industry Guide

DateMar, 2007
Pages180

€796 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:

Datamonitor's Pharmaceuticals Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Covers Global, European, Asia-Pacific & 11 individual country markets

* Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market generated total revenues of $555.5 billion in 2006, this representing a compound annual growth rate (CAGR) of 6.6% for the five-year period spanning 2002-2006.

Cardiovascular drug sales proved the most lucrative for the global pharmaceuticals market in 2006, generating total revenues of $106.2 billion, equivalent to 19.1% of the market's overall value.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.8% for the five-year period 2006-2011 expected to drive the market to a value of $703.5 billion by the end of 2011.

Why you should buy this report:

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2005 annual average exchange rates.

Market shares are for sales in 2005, the most recent full year results available.

For the purpose of this report, the European market is deemed to consist of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific consists of Australia, China, India, Japan, Singapore, South Korea and Taiwan.

The Americas consists of the US, Canada, Brazil and Mexico.

The global market consists of Europe, Asia-Pacific and the Americas.




Table of contents:
 Table of Contents
CHAPTER 1 Introduction 21
What is this report about? 21
Who is the target reader? 21
How to use this report 21
Definitions 22
CHAPTER 2 Global Pharmaceuticals 23
Market Overview 23
Market Value 25
Market Segmentation I 26
Market Segmentation II 27
Market Share 28
Competitive Landscape 29
Market Forecasts 30
CHAPTER 3 Pharmaceuticals in Asia Pacific 31
Market Overview 31
Market Value 32
Market Segmentation I 33
Market Segmentation II 34
Market Share 35
Competitive Landscape 36
Market Forecasts 37
CHAPTER 4 Pharmaceuticals in Europe 38
Market Overview 38
Market Value 39
Market Segmentation I 40
Market Segmentation II 41
Market Share 42
Competitive Landscape 43
Market Forecasts 44
Macroeconomic Indicators 45
CHAPTER 5 Pharmaceuticals in Belgium 46
Market Overview 46
Market Value 47
Market Segmentation I 48
Market Segmentation II 49
Market Share 50
Competitive Landscape 51
Market Forecasts 52
Macroeconomic Indicators 53
CHAPTER 6 Pharmaceuticals in Canada 54
Market Overview 54
Market Value 55
Market Segmentation I 56
Market Segmentation II 57
Market Share 58
Competitive Landscape 59
Market Forecasts 60
Macroeconomic Indicators 61
CHAPTER 7 Pharmaceuticals in China 63
Market Overview 63
Market Value 64
Market Segmentation I 65
Market Segmentation II 66
Market Share 67
Competitive Landscape 68
Market Forecasts 69
Macroeconomic Indicators 70
CHAPTER 8 Pharmaceuticals in France 72
Market Overview 72
Market Value 73
Market Segmentation I 74
Market Segmentation II 75
Market Share 76
Competitive Landscape 77
Market Forecasts 78
Macroeconomic Indicators 79
CHAPTER 9 Pharmaceuticals in Germany 81
Market Overview 81
Market Value 82
Market Segmentation I 83
Market Segmentation II 84
Market Share 85
Competitive Landscape 86
Market Forecasts 87
Macroeconomic Indicators 88
CHAPTER 10 Pharmaceuticals in Italy 90
Market Overview 90
Market Value 91
Market Segmentation I 92
Market Segmentation II 93
Market Share 94
Competitive Landscape 95
Market Forecasts 96
Macroeconomic Indicators 97
CHAPTER 11 Pharmaceuticals in Japan 99
Market Overview 99
Market Value 100
Market Segmentation I 101
Market Segmentation II 102
Market Share 103
Competitive Landscape 104
Market Forecasts 105
Macroeconomic Indicators 106
CHAPTER 12 Pharmaceuticals in the Netherlands 107
Market Overview 107
Market Value 108
Market Segmentation I 109
Market Segmentation II 110
Market Share 111
Competitive Landscape 112
Market Forecasts 113
Macroeconomic Indicators 114
CHAPTER 13 Pharmaceuticals in Spain 115
Market Overview 115
Market Value 116
Market Segmentation I 117
Market Segmentation II 118
Market Share 119
Competitive Landscape 120
Market Forecasts 121
Macroeconomic Indicators 122
CHAPTER 14 Pharmaceuticals in the United Kingdom 124
Market Overview 124
Market Value 125
Market Segmentation I 126
Market Segmentation II 127
Market Share 128
Competitive Landscape 129
Market Forecasts 130
Macroeconomic Indicators 131
CHAPTER 15 Pharmaceuticals in the United States 133
Market Overview 133
Market Value 134
Market Segmentation I 135
Market Segmentation II 136
Market Share 137
Competitive Landscape 138
Market Forecasts 139
Macroeconomic Indicators 140
CHAPTER 16 Company Profiles 141
GlaxoSmithKline Plc 141
Pfizer Inc 153
Sanofi-Aventis Group 166
CHAPTER 17 Appendix 179
Data Research Methodology 179
Report writing team 180


List of Tables
Table 1: Global Pharmaceuticals Market Value: $ billion, 2002-2006 25
Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2005 26
Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 27
Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2005 28
Table 5: Global Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 30
Table 6: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2002-2006 32
Table 7: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 33
Table 8: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 34
Table 9: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2005 35
Table 10: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 37
Table 11: Europe Pharmaceuticals Market Value: $ billion, 2002-2006 39
Table 12: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 40
Table 13: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 41
Table 14: Europe Pharmaceuticals Market Share: % Share, by Value, 2005 42
Table 15: Europe Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 44
Table 16: Europe Exchange Rate, 2002 45
Table 17: Belgium Pharmaceuticals Market Value: $ billion, 2002-2006 47
Table 18: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 48
Table 19: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 49
Table 20: Belgium Pharmaceuticals Market Share: % Share, by Value, 2005 50
Table 21: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 52
Table 22: Belgium Size of Population (million) , 2002-2006 53
Table 23: Belgium GDP (1995=100), 2002-2006 53
Table 24: Belgium Exchange Rate, 2002 53
Table 25: Canada Pharmaceuticals Market Value: $ billion, 2002-2006 55
Table 26: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 56
Table 27: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 57
Table 28: Canada Pharmaceuticals Market Share: % Share, by Value, 2005 58
Table 29: Canada Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 60
Table 30: Canada Size of Population (million) , 2002-2006 61
Table 31: Canada GDP (1995=100), 2002-2006 61
Table 32: Canada Inflation, 2002-2006 61
Table 33: Canada Exchange Rate, 2002 62
Table 34: China Pharmaceuticals Market Value: $ billion, 2002-2006 64
Table 35: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 65
Table 36: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 66
Table 37: China Pharmaceuticals Market Share: % Share, by Value, 2005 67
Table 38: China Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 69
Table 39: China Size of Population (million) , 2002-2006 70
Table 40: China GDP (1995=100), 2002-2006 70
Table 41: China Inflation, 2002-2006 70
Table 42: China Exchange Rate, 2002 71
Table 43: France Pharmaceuticals Market Value: $ billion, 2002-2006 73
Table 44: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 74
Table 45: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 75
Table 46: France Pharmaceuticals Market Share: % Share, by Value, 2005 76
Table 47: France Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 78
Table 48: France Size of Population (million) , 2002-2006 79
Table 49: France GDP (1995=100), 2002-2006 79
Table 50: France Inflation, 2002-2006 79
Table 51: France Exchange Rate, 2002 80
Table 52: Germany Pharmaceuticals Market Value: $ billion, 2002-2006 82
Table 53: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 83
Table 54: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 84
Table 55: Germany Pharmaceuticals Market Share: % Share, by Value, 2005 85
Table 56: Germany Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 87
Table 57: Germany Size of Population (million) , 2002-2006 88
Table 58: Germany GDP (1995=100), 2002-2006 88
Table 59: Germany Inflation, 2002-2006 88
Table 60: Germany Exchange Rate, 2002 89
Table 61: Italy Pharmaceuticals Market Value: $ billion, 2002-2006 91
Table 62: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 92
Table 63: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 93
Table 64: Italy Pharmaceuticals Market Share: % Share, by Value, 2005 94
Table 65: Italy Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 96
Table 66: Italy Size of Population (million) , 2002-2006 97
Table 67: Italy GDP (1995=100), 2002-2006 97
Table 68: Italy Inflation, 2002-2006 97
Table 69: Italy Exchange Rate, 2002 98
Table 70: Japan Pharmaceuticals Market Value: $ billion, 2002-2006 100
Table 71: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 101
Table 72: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 102
Table 73: Japan Pharmaceuticals Market Share: % Share, by Value, 2005 103
Table 74: Japan Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 105
Table 75: Japan Size of Population (million) , 2002-2006 106
Table 76: Japan GDP (1995=100), 2002-2006 106
Table 77: Japan Exchange Rate, 2002 106
Table 78: Netherlands Pharmaceuticals Market Value: $ billion, 2002-2006 108
Table 79: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 109
Table 80: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 110
Table 81: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2005 111
Table 82: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 113
Table 83: Netherlands Size of Population (million) , 2002-2006 114
Table 84: Netherlands GDP (1995=100), 2002-2006 114
Table 85: Netherlands Exchange Rate, 2002 114
Table 86: Spain Pharmaceuticals Market Value: $ billion, 2002-2006 116
Table 87: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 117
Table 88: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 118
Table 89: Spain Pharmaceuticals Market Share: % Share, by Value, 2005 119
Table 90: Spain Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 121
Table 91: Spain Size of Population (million) , 2002-2006 122
Table 92: Spain GDP (1995=100), 2002-2006 122
Table 93: Spain Inflation, 2002-2006 122
Table 94: Spain Exchange Rate, 2002 123
Table 95: United Kingdom Pharmaceuticals Market Value: $ billion, 2002-2006 125
Table 96: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 126
Table 97: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 127
Table 98: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2005 128
Table 99: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 130
Table 100: United Kingdom Size of Population (million) , 2002-2006 131
Table 101: United Kingdom GDP (1995=100), 2002-2006 131
Table 102: United Kingdom Inflation, 2002-2006 131
Table 103: United Kingdom Exchange Rate, 2002 132
Table 104: United States Pharmaceuticals Market Value: $ billion, 2002-2006 134
Table 105: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 135
Table 106: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 136
Table 107: United States Pharmaceuticals Market Share: % Share, by Value, 2005 137
Table 108: United States Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 139
Table 109: United States Size of Population (million) , 2002-2006 140
Table 110: United States GDP (1995=100), 2002-2006 140
Table 111: United States Inflation, 2002-2006 140
Table 112: Key Facts 141
Table 113: SWOT Analysis 147
Table 114: Key Facts 153
Table 115: SWOT Analysis 158
Table 116: Key Facts 166
Table 117: SWOT Analysis 171


List of Figures
Figure 1: Global Pharmaceuticals Market Value: $ billion, 2002-2006 25
Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2005 26
Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 27
Figure 4: Global Pharmaceuticals Market Share: % Share, by Value, 2005 28
Figure 5: Global Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 30
Figure 6: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2002-2006 32
Figure 7: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 33
Figure 8: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 34
Figure 9: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2005 35
Figure 10: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 37
Figure 11: Europe Pharmaceuticals Market Value: $ billion, 2002-2006 39
Figure 12: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 40
Figure 13: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 41
Figure 14: Europe Pharmaceuticals Market Share: % Share, by Value, 2005 42
Figure 15: Europe Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 44
Figure 16: Belgium Pharmaceuticals Market Value: $ billion, 2002-2006 47
Figure 17: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 48
Figure 18: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 49
Figure 19: Belgium Pharmaceuticals Market Share: % Share, by Value, 2005 50
Figure 20: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 52
Figure 21: Canada Pharmaceuticals Market Value: $ billion, 2002-2006 55
Figure 22: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 56
Figure 23: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2005 57
Figure 24: Canada Pharmaceuticals Market Share: % Share, by Value, 2005 58
Figure 25: Canada Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 60
Figure 26: China Pharmaceuticals Market Value: $ billion, 2002-2006 64
Figure 27: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 65
Figure 28: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 66
Figure 29: China Pharmaceuticals Market Share: % Share, by Value, 2005 67
Figure 30: China Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 69
Figure 31: France Pharmaceuticals Market Value: $ billion, 2002-2006 73
Figure 32: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 74
Figure 33: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 75
Figure 34: France Pharmaceuticals Market Share: % Share, by Value, 2005 76
Figure 35: France Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 78
Figure 36: Germany Pharmaceuticals Market Value: $ billion, 2002-2006 82
Figure 37: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 83
Figure 38: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 84
Figure 39: Germany Pharmaceuticals Market Share: % Share, by Value, 2005 85
Figure 40: Germany Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 87
Figure 41: Italy Pharmaceuticals Market Value: $ billion, 2002-2006 91
Figure 42: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 92
Figure 43: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 93
Figure 44: Italy Pharmaceuticals Market Share: % Share, by Value, 2005 94
Figure 45: Italy Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 96
Figure 46: Japan Pharmaceuticals Market Value: $ billion, 2002-2006 100
Figure 47: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 101
Figure 48: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 102
Figure 49: Japan Pharmaceuticals Market Share: % Share, by Value, 2005 103
Figure 50: Japan Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 105
Figure 51: Netherlands Pharmaceuticals Market Value: $ billion, 2002-2006 108
Figure 52: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 109
Figure 53: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 110
Figure 54: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2005 111
Figure 55: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 113
Figure 56: Spain Pharmaceuticals Market Value: $ billion, 2002-2006 116
Figure 57: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 117
Figure 58: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 118
Figure 59: Spain Pharmaceuticals Market Share: % Share, by Value, 2005 119
Figure 60: Spain Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 121
Figure 61: United Kingdom Pharmaceuticals Market Value: $ billion, 2002-2006 125
Figure 62: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 126
Figure 63: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 127
Figure 64: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2005 128
Figure 65: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 130
Figure 66: United States Pharmaceuticals Market Value: $ billion, 2002-2006 134
Figure 67: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2006 135
Figure 68: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2006 136
Figure 69: United States Pharmaceuticals Market Share: % Share, by Value, 2005 137
Figure 70: United States Pharmaceuticals Market Value Forecast: $ billion, 2006-2011 139




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com